Equities

Applied BioCode Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6598:TAI

Applied BioCode Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)24.05
  • Today's Change0.00 / 0.00%
  • Shares traded345.24k
  • 1 Year change+2.12%
  • Beta0.9536
Data delayed at least 20 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Applied BioCode Corp is engaged in the provision of digital biological barcode detection technology platforms and related products. The Company's products mainly include digital biological barcodes, optical analyzers, in vitro diagnostic reagents, and others. The Company sells products in the United States, Europe and Asian markets.

  • Revenue in TWD (TTM)443.69m
  • Net income in TWD-207.78m
  • Incorporated2016
  • Employees--
  • Location
    Applied BioCode Corp6F, No.1, Lane 28Xingzhong Road, Neihu DistrictTAIPEI 114TaiwanTWN
  • Phone+886 287916833
  • Fax+886 287919117
  • Websitehttps://www.apbiocode.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Abnova Taiwan Corp355.40m1.80m1.54bn190.00880.821.2449.754.320.02880.02885.8620.520.26430.44378.24--0.13393.690.14053.8943.6146.160.506511.917.622.160.015886.00-7.01-3.0241.0579.976.1855.18
Applied BioCode Corp443.69m-207.78m2.47bn----3.60--5.57-2.11-2.114.456.690.38951.037.73---18.24-16.21-20.10-17.6758.1262.36-46.83-50.276.41--0.0833---13.1826.79-58.84---21.24--
Data as of Feb 11 2026. Currency figures normalised to Applied BioCode Corp's reporting currency: Taiwan Dollar TWD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.